CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...